Trial Profile
Phase I Clinical Trial of Temsirolimus and Vinorelbine in Advanced Solid Tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Jun 2016
Price :
$35
*
At a glance
- Drugs Temsirolimus (Primary) ; Vinorelbine
- Indications Advanced breast cancer; Cervical cancer; Lung cancer; Neuroendocrine tumours; Ovarian cancer; Prostate cancer; Renal cancer; Solid tumours; Uterine cancer
- Focus Adverse reactions; Therapeutic Use
- 09 Jun 2016 Status changed from active, no longer recruiting to completed.
- 29 Mar 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov record .
- 27 Jan 2014 According to ClinicalTrials.gov record, planned End Date changed from 1 Jan 2014 to 1 Dec 2014.